Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity.

Hartz AM, Mahringer A, Miller DS, Bauer B.

J Cereb Blood Flow Metab. 2010 Oct;30(10):1742-55. doi: 10.1038/jcbfm.2010.36. Epub 2010 Mar 10.

2.
3.

BCRP at the blood-brain barrier: genomic regulation by 17β-estradiol.

Mahringer A, Fricker G.

Mol Pharm. 2010 Oct 4;7(5):1835-47. doi: 10.1021/mp1001729. Epub 2010 Sep 9.

PMID:
20735085
4.

In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.

Hoque MT, Shah A, More V, Miller DS, Bendayan R.

J Neurochem. 2015 Dec;135(6):1113-22. doi: 10.1111/jnc.13389. Epub 2015 Nov 13.

5.

The xenoestrogens ethinylestradiol and bisphenol A regulate BCRP at the blood-brain barrier of rats.

Nickel S, Mahringer A.

Xenobiotica. 2014 Nov;44(11):1046-54. doi: 10.3109/00498254.2014.922226. Epub 2014 Jun 19.

PMID:
24945792
6.

Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers.

Wang X, Campos CR, Peart JC, Smith LK, Boni JL, Cannon RE, Miller DS.

J Neurosci. 2014 Jun 18;34(25):8585-93. doi: 10.1523/JNEUROSCI.2935-13.2014.

7.

Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.

Wang H, Zhou L, Gupta A, Vethanayagam RR, Zhang Y, Unadkat JD, Mao Q.

Am J Physiol Endocrinol Metab. 2006 May;290(5):E798-807. Epub 2005 Dec 13.

8.

Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.

Lee YJ, Kusuhara H, Jonker JW, Schinkel AH, Sugiyama Y.

J Pharmacol Exp Ther. 2005 Jan;312(1):44-52. Epub 2004 Sep 24.

9.

Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.

Wang X, Sykes DB, Miller DS.

Mol Pharmacol. 2010 Sep;78(3):376-83. doi: 10.1124/mol.110.063685. Epub 2010 Jun 14.

10.

P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats.

Reichel V, Burghard S, John I, Huber O.

Brain Res. 2011 Jan 25;1370:238-45. doi: 10.1016/j.brainres.2010.11.012. Epub 2010 Nov 12.

PMID:
21075088
11.
12.

ABC transporter function and regulation at the blood-spinal cord barrier.

Campos CR, Schröter C, Wang X, Miller DS.

J Cereb Blood Flow Metab. 2012 Aug;32(8):1559-66. doi: 10.1038/jcbfm.2012.47. Epub 2012 Apr 4.

13.

Glutamate-Mediated Down-Regulation of the Multidrug-Resistance Protein BCRP/ABCG2 in Porcine and Human Brain Capillaries.

Salvamoser JD, Avemary J, Luna-Munguia H, Pascher B, Getzinger T, Pieper T, Kudernatsch M, Kluger G, Potschka H.

Mol Pharm. 2015 Jun 1;12(6):2049-60. doi: 10.1021/mp500841w. Epub 2015 Apr 30.

PMID:
25898179
14.

Generation and Characterization of a Breast Cancer Resistance Protein Humanized Mouse Model.

Dallas S, Salphati L, Gomez-Zepeda D, Wanek T, Chen L, Chu X, Kunta J, Mezler M, Menet MC, Chasseigneaux S, Declèves X, Langer O, Pierre E, DiLoreto K, Hoft C, Laplanche L, Pang J, Pereira T, Andonian C, Simic D, Rode A, Yabut J, Zhang X, Scheer N.

Mol Pharmacol. 2016 May;89(5):492-504. doi: 10.1124/mol.115.102079. Epub 2016 Feb 18.

16.

Regulation of ABC transporters blood-brain barrier: the good, the bad, and the ugly.

Miller DS.

Adv Cancer Res. 2015;125:43-70. doi: 10.1016/bs.acr.2014.10.002. Epub 2015 Jan 8. Review.

PMID:
25640266
17.
18.

Production of proinflammatory cytokines and chemokines during neuroinflammation: novel roles for estrogen receptors alpha and beta.

Brown CM, Mulcahey TA, Filipek NC, Wise PM.

Endocrinology. 2010 Oct;151(10):4916-25. doi: 10.1210/en.2010-0371. Epub 2010 Aug 4.

19.

Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation.

Yousif S, Chaves C, Potin S, Margaill I, Scherrmann JM, Declèves X.

J Neurochem. 2012 Nov;123(4):491-503. doi: 10.1111/j.1471-4159.2012.07890.x. Epub 2012 Sep 3.

20.

Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.

Narang VS, Fraga C, Kumar N, Shen J, Throm S, Stewart CF, Waters CM.

Am J Physiol Cell Physiol. 2008 Aug;295(2):C440-50. doi: 10.1152/ajpcell.00491.2007. Epub 2008 Jun 4.

Supplemental Content

Support Center